CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 235 enrolled
Drug / intervention
0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01068964
NCT01068964N/ACompleted
CompareCT.gov

Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

Allergan·interventional·Posted Feb 17, 2010·Updated Apr 17, 2019

In Brief

A clinical study evaluating 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution and 0.03% Bimatoprost Ophthalmic Solution and 0.5% Timolol Ophthalmic Solution for Open-angle Glaucoma and Ocular Hypertension. Completed, enrolled 235 participants across 1 site.

Detailed Summary

This study will evaluate the safety and efficacy of once daily administered 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution compared with once daily administered 0.03% Bimatoprost Ophthalmic Solution and once daily administered 0.5% Timolol Ophthalmic Solution concurrently in patients with open-angle glaucoma or ocular hypertension

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpen-angle Glaucoma, Ocular Hypertension
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 17, 2010
Enrollment StartFeb 1, 2010
Primary CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 16.4 years ago

Interventions

0.03% Bimatoprost/0.5% Timolol Ophthalmic Solutiondrug

One drop from each bottle, administered once daily in the evening for 4 weeks Bottle 1: 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution Bottle 2: Vehicle Ophthalmic Solution

0.03% Bimatoprost Ophthalmic Solution and 0.5% Timolol Ophthalmic Solutiondrug

One drop from each bottle, administered once daily in the evening for 4 weeks Bottle 1: 0.03% Bimatoprost Ophthalmic Solution Bottle 2: 0.5% Timolol Ophthalmic Solution